Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bart Smets

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Molecular Biology of the Cell|November 8, 2013
The protein kinase Sch9 is a key regulator of sphingolipid metabolism in Saccharomyces cerevisiaeErwin Swinnen, Tobias Wilms, Jolanta Idkowiak-Baldys, et al.
Molecular Neurodegeneration|November 29, 2023
Characterization of APOE Christchurch carriers in 455,306 UK Biobank participantsKaren Y He, Ekaterina A Khramtsova, Alfredo Cabrera-Socorro, et al.
Medrxiv : the Preprint Server for Health Sciences|August 13, 2025
Proteomic signatures of the <i>APOE ε4</i> and <i>APOE ε2</i> genetic variants and Alzheimer's diseaseLina Lu, Alexa Pichet Binette, Ines Hristovska, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersLijun An, Yu Xiao, Ines Hristovska, et al.
Nature Aging|May 15, 2026
Proteomic signatures of the APOE ε4 and APOE ε2 genetic variants and Alzheimer's diseaseLina Lu, Alexa Pichet Binette, Ines Hristovska, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersPablo García-González, Raquel Puerta, Jonas Dehairs, et al.
Medrxiv : the Preprint Server for Health Sciences|July 9, 2025
Benchmarking the AI-based diagnostic potential of plasma proteomics for neurodegenerative disease in 17,170 peopleLijun An, Alexa Pichet-Binette, Ines Hristovska, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 6, 2013
Preclinical characterization of GLPG0634, a selective inhibitor of JAK1, for the treatment of inflammatory diseasesLuc Van Rompaey, René Galien, Ellen M van der Aar, et al.
Nature Medicine|March 31, 2026
A deep joint-learning proteomics model for diagnosis of six conditions associated with dementiaLijun An, Alexa Pichet Binette, Ines Hristovska, et al.
International Journal of Molecular Sciences|January 11, 2025
Head-to-Head Comparison of Aptamer- and Antibody-Based Proteomic Platforms in Human Cerebrospinal Fluid Samples from a Real-World Memory Clinic CohortRaquel Puerta, Amanda Cano, Pablo García-González, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Molecular Biology of the Cell|November 8, 2013
The protein kinase Sch9 is a key regulator of sphingolipid metabolism in Saccharomyces cerevisiaeErwin Swinnen, Tobias Wilms, Jolanta Idkowiak-Baldys, et al.
Molecular Neurodegeneration|November 29, 2023
Characterization of APOE Christchurch carriers in 455,306 UK Biobank participantsKaren Y He, Ekaterina A Khramtsova, Alfredo Cabrera-Socorro, et al.
Medrxiv : the Preprint Server for Health Sciences|August 13, 2025
Proteomic signatures of the <i>APOE ε4</i> and <i>APOE ε2</i> genetic variants and Alzheimer's diseaseLina Lu, Alexa Pichet Binette, Ines Hristovska, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersLijun An, Yu Xiao, Ines Hristovska, et al.
Nature Aging|May 15, 2026
Proteomic signatures of the APOE ε4 and APOE ε2 genetic variants and Alzheimer's diseaseLina Lu, Alexa Pichet Binette, Ines Hristovska, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersPablo García-González, Raquel Puerta, Jonas Dehairs, et al.
Medrxiv : the Preprint Server for Health Sciences|July 9, 2025
Benchmarking the AI-based diagnostic potential of plasma proteomics for neurodegenerative disease in 17,170 peopleLijun An, Alexa Pichet-Binette, Ines Hristovska, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 6, 2013
Preclinical characterization of GLPG0634, a selective inhibitor of JAK1, for the treatment of inflammatory diseasesLuc Van Rompaey, René Galien, Ellen M van der Aar, et al.
Nature Medicine|March 31, 2026
A deep joint-learning proteomics model for diagnosis of six conditions associated with dementiaLijun An, Alexa Pichet Binette, Ines Hristovska, et al.
International Journal of Molecular Sciences|January 11, 2025
Head-to-Head Comparison of Aptamer- and Antibody-Based Proteomic Platforms in Human Cerebrospinal Fluid Samples from a Real-World Memory Clinic CohortRaquel Puerta, Amanda Cano, Pablo García-González, et al.
Pageof 3